This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sundlof, G. Articles by Nerhed, C. Search for Related Content PubMed PubMed Citation Articles by Sundlof, G. Articles by Nerhed, C.

Hypertension, Vol 5, 749-756, Copyright © 1983 by American Heart Association

ARTICLES

Acute effects of metoprolol on muscle sympathetic activity in hypertensive humans

G Sundlof, BG Wallin, E Stromgren and C Nerhed

Recordings of multiunit sympathetic activity were made from muscle branches of the peroneal nerve in eight previously untreated subjects with essential hypertension during intravenous administration of the cardioselective beta-adrenoceptor antagonist, metoprolol. Intraarterial blood pressure and central venous pressure were monitored simultaneously. After metoprolol, heart rate fell and central venous pressure increased in all subjects. Blood pressure increased in some subjects and decreased in others whereas the rate of rise of the systolic pulse wave regularly decreased. Sympathetic activity, discharged in pulse synchronous bursts of action potentials, was quantitated by counting the number of bursts and their amplitudes in the mean voltage neurogram. In all subjects, the average diastole was associated with outflow of more sympathetic impulses after metoprolol than before. Total sympathetic activity (expressed as bursts/min multiplied by mean burst strength) also increased after the drug. The mechanism behind the increase of sympathetic activity may be either a direct central nervous effect or a reflex effect elicited from arterial baroreceptors or cardiac receptors.

This article has been cited by other articles:

				S.P. Beloka, S. Gouveia, M. Gujic, R. Naeije, A.P. Rocha, and P. van de Borne Differential Effects of Oral {beta} Blockade on Cardiovascular and Sympathetic Regulation Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 323 - 331. [Abstract] [PDF]

				Q. Fu, R. Zhang, S. Witkowski, A. Arbab-Zadeh, A. Prasad, K. Okazaki, and B. D. Levine Persistent Sympathetic Activation During Chronic Antihypertensive Therapy: A Potential Mechanism for Long Term Morbidity? Hypertension, April 1, 2005; 45(4): 513 - 521. [Abstract] [Full Text] [PDF]

				C. Cogliati, S. Colombo, T. G. Ruscone, D. Gruosso, A. Porta, N. Montano, A. Malliani, and R. Furlan Acute {beta}-Blockade Increases Muscle Sympathetic Activity and Modifies Its Frequency Distribution Circulation, November 2, 2004; 110(18): 2786 - 2791. [Abstract] [Full Text] [PDF]

				J. Burns, D. A.S.G. Mary, A. F. Mackintosh, S. G. Ball, and J. P. Greenwood Arterial Pressure Lowering Effect of Chronic Atenolol Therapy in Hypertension and Vasoconstrictor Sympathetic Drive Hypertension, October 1, 2004; 44(4): 454 - 458. [Abstract] [Full Text] [PDF]

				G. Grassi, G. Seravalle, C. Turri, G. Bolla, and G. Mancia Short-Versus Long-Term Effects of Different Dihydropyridines on Sympathetic and Baroreflex Function in Hypertension Hypertension, March 1, 2003; 41(3): 558 - 562. [Abstract] [Full Text] [PDF]

				G. E. Newton and J. D. Parker Acute Effects of ß1-Selective and Nonselective ß-Adrenergic Receptor Blockade on Cardiac Sympathetic Activity in Congestive Heart Failure Circulation, August 1, 1996; 94(3): 353 - 358. [Abstract] [Full Text]